5,689 The Clorox Company $CLX Shares Bought by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. lifted its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 23.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 30,400 shares of the company’s stock after purchasing an additional 5,689 shares during the period. Oppenheimer & Co. Inc.’s holdings in Clorox were worth $2,463,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. BlackRock Inc. bought a new position in Clorox in the 2nd quarter worth approximately $958,640,000. Bank of America Corp DE bought a new position in Clorox in the 2nd quarter valued at $179,780,000. Royal Bank of Canada boosted its position in Clorox by 20.1% in the 1st quarter. Royal Bank of Canada now owns 1,418,204 shares of the company’s stock valued at $146,969,000 after buying an additional 237,301 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of Clorox by 2.3% in the 1st quarter. Bank of New York Mellon Corp now owns 1,280,226 shares of the company’s stock valued at $132,670,000 after buying an additional 29,181 shares during the period. Finally, Confluence Investment Management LLC increased its stake in shares of Clorox by 33.8% in the 2nd quarter. Confluence Investment Management LLC now owns 1,247,644 shares of the company’s stock valued at $119,075,000 after buying an additional 315,069 shares during the period. 78.53% of the stock is owned by institutional investors.

Key Clorox News

Here are the key news stories impacting Clorox this week:

  • Positive Sentiment: New CEO appointed: Clorox named Fabian Garcia, a veteran consumer-products executive from Unilever, as CEO and chair effective January 5, 2027. His experience could help strengthen brand execution and support a turnaround after a comprehensive search. Matthew Shattock will resume his role as independent chair, while Linda Rendle is stepping down for health reasons. Clorox Appoints Fabian Garcia as CEO
  • Positive Sentiment: Potential earnings support: Analysts expect fiscal first-quarter 2027 results to benefit from product innovation, brand investments and the contribution from GOJO, the hand-care business acquired by Clorox. A stronger-than-expected report could provide a near-term catalyst. Clorox’s Q1 Earnings Coming Up: Key Insights for Investors
  • Neutral Sentiment: Valuation is being debated: Recent commentary suggests CLX may be fairly valued based on expected earnings, while the incoming CEO could make the stock appear inexpensive if he improves growth and profitability. Investors are likely to focus on guidance and the pace of recovery rather than valuation alone. Clorox Stock Looks About Right Based on Earnings
  • Negative Sentiment: Profitability and dividend risks remain: Higher costs, cautious consumer spending and potential pressure on margins may limit the benefit from innovation and GOJO. Analysts also view the dividend as facing a more difficult test, making cash flow and management’s outlook key issues in the earnings release. Clorox: An Easy Quarter Ahead, But a Harder Test for the Dividend

Analyst Ratings Changes

CLX has been the topic of several research reports. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $95.00 price target on shares of Clorox in a research note on Monday, October 19th. Wells Fargo & Company lowered their price objective on Clorox from $90.00 to $85.00 and set an “equal weight” rating for the company in a research report on Monday, October 5th. Zacks Research upgraded Clorox from a “strong sell” rating to a “hold” rating in a research report on Monday, September 14th. Wall Street Zen cut Clorox from a “hold” rating to a “sell” rating in a report on Saturday, October 3rd. Finally, Jefferies Financial Group downgraded shares of Clorox from a “buy” rating to a “hold” rating and cut their target price for the company from $125.00 to $98.00 in a research report on Tuesday, July 28th. Twelve research analysts have rated the stock with a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, Clorox currently has an average rating of “Reduce” and a consensus price target of $93.57.

Read Our Latest Report on CLX

Clorox Stock Performance

Shares of Clorox stock opened at $88.01 on Friday. The firm has a fifty day moving average of $88.61 and a two-hundred day moving average of $100.01. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The stock has a market capitalization of $10.64 billion, a price-to-earnings ratio of 18.26, a PEG ratio of 2.97 and a beta of 0.59. The Clorox Company has a 52 week low of $79.12 and a 52 week high of $128.90.

Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings results on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%. The business had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.91 billion. During the same period last year, the company earned $2.87 EPS. The firm’s revenue was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, equities research analysts predict that The Clorox Company will post 5.66 EPS for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 5.7%. The ex-dividend date is Wednesday, October 28th. Clorox’s payout ratio is presently 103.73%.

About Clorox

(Free Report)

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.

Featured Articles

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.